You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ONZETRA XSAIL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ONZETRA XSAIL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03338920 ↗	Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents	Recruiting	Avanir Pharmaceuticals	Phase 3	2017-11-02	This study will be conducted to evaluate the safety and efficacy of sumatriptan nasal powder (AVP-825) compared to placebo in the acute treatment of migraine in adolescent participants, 12 through 17 years of age.
NCT03338920 ↗	Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents	Recruiting	Currax Pharmaceuticals	Phase 3	2017-11-02	This study will be conducted to evaluate the safety and efficacy of sumatriptan nasal powder (AVP-825) compared to placebo in the acute treatment of migraine in adolescent participants, 12 through 17 years of age.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ONZETRA XSAIL

Condition Name

Chart
Table

Condition Name for ONZETRA XSAIL
Intervention	Trials
Acute Migraine With or Without Aura	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ONZETRA XSAIL
Intervention	Trials
Migraine Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ONZETRA XSAIL

Trials by Country

Map
Table

Trials by Country for ONZETRA XSAIL
Location	Trials
United States	26
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ONZETRA XSAIL
Location	Trials
Utah	1
Texas	1
Pennsylvania	1
Oregon	1
Oklahoma	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ONZETRA XSAIL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ONZETRA XSAIL
Clinical Trial Phase	Trials
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ONZETRA XSAIL
Clinical Trial Phase	Trials
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ONZETRA XSAIL

Sponsor Name

Chart
Table

Sponsor Name for ONZETRA XSAIL
Sponsor	Trials
Avanir Pharmaceuticals	1
Currax Pharmaceuticals	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ONZETRA XSAIL
Sponsor	Trials
Industry	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.